Description

Solian (amisulpride) tablets 200 mg. №30

Ingredients

Active ingredient: Amisulpride 200 mg per tablet.

Dosage

Recommended dosage: The usual dose is 200-800 mg daily, divided into two doses.

Indications

Indicated for: Treatment of schizophrenia.

Contraindications

Do not use if: Hypersensitive to amisulpride or any component of the formulation.

Directions

Administration: Take the tablets orally with water, with or without food.

Scientific Evidence

Amisulpride, the active ingredient in Solian tablets, is a second-generation antipsychotic that primarily acts as a selective dopamine antagonist. It exerts its therapeutic effects by blocking dopamine D2 and D3 receptors in the brain, leading to an improvement in positive and negative symptoms of schizophrenia.

Several clinical trials have demonstrated the efficacy of amisulpride in the treatment of schizophrenia. A study by Leucht et al. (2013) compared the effectiveness of different antipsychotic drugs and found that amisulpride was as effective as other antipsychotics in treating acute exacerbations of schizophrenia.

Additional Information

It is important to monitor patients for any signs of neuroleptic malignant syndrome, tardive dyskinesia, or other serious side effects while on Solian treatment. Consult a healthcare professional for proper evaluation and management.

Patients should be advised not to discontinue Solian abruptly, as it may lead to withdrawal symptoms. Gradual dose reduction under medical supervision is recommended to avoid adverse effects.